Repligen Management
Management criteria checks 4/4
Repligen's CEO is Olivier Loeillot, appointed in Oct 2023, has a tenure of 1.08 years. total yearly compensation is $7.18M, comprised of 9% salary and 91% bonuses, including company stock and options. directly owns 0.013% of the company’s shares, worth $1.02M. The average tenure of the management team and the board of directors is 2 years and 9.6 years respectively.
Key information
Olivier Loeillot
Chief executive officer
US$7.2m
Total compensation
| CEO salary percentage | 9.05% |
| CEO tenure | 2yrs |
| CEO ownership | 0.01% |
| Management average tenure | 2yrs |
| Board average tenure | 9.6yrs |
Recent management updates
Recent updates
Repligen Corporation Just Beat EPS By 18%: Here's What Analysts Think Will Happen Next
Oct 31
Why Investors Shouldn't Be Surprised By Repligen Corporation's (NASDAQ:RGEN) 28% Share Price Surge
Oct 04Is Repligen (NASDAQ:RGEN) A Risky Investment?
Sep 01Why Investors Shouldn't Be Surprised By Repligen Corporation's (NASDAQ:RGEN) P/S
Jul 29Repligen: Long-Term Growth Gem Suffers Some Setbacks
Jun 08
Biomanufacturing Expansion Will Create New Global Opportunities
Strong demand in biomanufacturing and effective market expansion are driving sustained revenue growth and improved margins for Repligen.Repligen: Ongoing Bioprocessing Market Recovery
Mar 20Is Repligen (NASDAQ:RGEN) A Risky Investment?
Feb 12Repligen Corporation's Earnings Preview: Expensive With Mixed Growth Prospects
Nov 12Repligen (NASDAQ:RGEN) Has A Pretty Healthy Balance Sheet
Nov 08Repligen: Strong Filtration Growth, Offset By Other Challenges
Jul 13Repligen Stock: Still Quite Overvalued
May 30CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | US$2m |
| Jun 30 2025 | n/a | n/a | -US$14m |
| Mar 31 2025 | n/a | n/a | -US$23m |
| Dec 31 2024 | US$7m | US$650k | -US$26m |
| Sep 30 2024 | n/a | n/a | -US$8m |
| Jun 30 2024 | n/a | n/a | US$9m |
| Mar 31 2024 | n/a | n/a | US$24m |
| Dec 31 2023 | US$5m | US$138k | US$36m |
Compensation vs Market: Olivier's total compensation ($USD7.18M) is about average for companies of similar size in the US market ($USD8.55M).
Compensation vs Earnings: Olivier's compensation has been consistent with company performance over the past year.
CEO
Olivier Loeillot (55 yo)
Mr. Olivier Loeillot is President of Repligen Corporation from October 02, 2023 & served as it's Chief Commercial Officer and serves as it's CEO & Director since September 1, 2024. Mr. Loeillot served a co...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chair | 10.4yrs | US$20.30m | 0.14% $ 11.7m | |
| President | 2yrs | US$7.18m | 0.013% $ 1.0m | |
| CFO & Chief Compliance Officer | 2.1yrs | US$2.11m | 0.0035% $ 282.2k | |
| Chief Operating Officer | 5.6yrs | US$4.17m | 0.014% $ 1.1m | |
| Senior Vice President of Research & Development | 9yrs | US$1.99m | 0.014% $ 1.1m | |
| Chief Accounting Officer | less than a year | no data | no data | |
| Chief Information Officer | less than a year | no data | no data | |
| Global Head of Investor Relations | no data | no data | no data | |
| Vice President of Legal | less than a year | no data | no data | |
| Senior Vice President of Sales | 3yrs | no data | no data | |
| Senior Director of Marketing | 1.8yrs | no data | no data | |
| Global Head of Human Resources & VP | 2.8yrs | no data | no data |
Experienced Management: RGEN's management team is considered experienced (2 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chair | 10.4yrs | US$20.30m | 0.14% $ 11.7m | |
| President | 1.1yrs | US$7.18m | 0.013% $ 1.0m | |
| Independent Director | 10yrs | US$338.32k | 0.057% $ 4.7m | |
| Member of Scientific Advisory Board | 9.6yrs | no data | no data | |
| Independent Director | 2.7yrs | US$316.98k | 0.011% $ 928.8k | |
| Lead Independent Director | 20.1yrs | US$428.40k | 0.16% $ 13.2m | |
| Independent Director | 1.6yrs | US$540.49k | 0.0019% $ 150.5k | |
| Member of Scientific Advisory Board | 9.6yrs | no data | no data | |
| Member of Scientific Advisory Board & Independent Director | 9.6yrs | US$301.65k | 0.0034% $ 277.3k | |
| Member of Scientific Advisory Board | 9.6yrs | no data | no data | |
| Independent Director | 5.6yrs | US$306.65k | 0.0054% $ 440.0k | |
| Independent Director | 11.3yrs | US$324.98k | 0.0062% $ 501.0k |
Experienced Board: RGEN's board of directors are considered experienced (9.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/10/31 10:16 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Repligen Corporation is covered by 31 analysts. 19 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Luke Sergott | Barclays |
| Robert Wasserman | Benchmark Company |
| Hugo Solvet | BNP Paribas |